Verify patient identity, review current electrolyte panel, coagulation profile, and hemodynamic stability. Ensure vascular access site is clean and patent. Obtain informed consent. Baseline vital signs and patient weight must be recorded. Pre-medication as per standing orders if required.
Post-procedure, assess vital signs for hemodynamic stability after circuit disconnection. Ensure meticulous hemostasis at the vascular access site and apply a sterile dressing. Monitor for adverse effects like dizziness or cramping. Patient is cleared for discharge once hemodynamically stable and symptoms are resolved.
Clinical Guide: Sustained Low-Efficiency Dialysis (SLED / PIRRT)
1. Comprehensive Introduction & Overview
Sustained Low-Efficiency Dialysis (SLED), often categorized under the umbrella of Prolonged Intermittent Renal Replacement Therapy (PIRRT), represents a hybrid modality in the management of Acute Kidney Injury (AKI) in critically ill patients. It bridges the gap between conventional Intermittent Hemodialysis (IHD) and Continuous Renal Replacement Therapy (CRRT).
In the high-acuity environment of the Intensive Care Unit (ICU), hemodynamic instability often precludes the use of rapid, high-flux IHD. Conversely, CRRT, while hemodynamically gentle, requires complex equipment, specialized nursing oversight, and high costs. SLED provides a "middle ground," utilizing standard dialysis machines to deliver dialysis over a prolonged period (typically 6 to 12 hours) at lower blood and dialysate flow rates. This allows for effective solute clearance and volume management while minimizing the cardiovascular stressors associated with rapid fluid shifts.
2. Deep-Dive into Technical Specifications & Mechanisms
The fundamental principle of SLED is the reduction of the "efficiency" of solute removal per unit of time, which is compensated for by increasing the total duration of the treatment session.
Technical Parameters Comparison
| Parameter | IHD (Standard) | SLED / PIRRT | CRRT |
|---|---|---|---|
| Duration | 3–4 Hours | 6–12 Hours | 24 Hours |
| Blood Flow (Qb) | 300–400 mL/min | 150–250 mL/min | 100–200 mL/min |
| Dialysate Flow (Qd) | 500–800 mL/min | 100–300 mL/min | 15–35 mL/min (Effluent) |
| Solute Clearance | High/Rapid | Moderate/Gradual | Low/Constant |
| Equipment | Standard Dialysis | Standard Dialysis | Specialized CRRT Machine |
Mechanisms of Action
- Diffusion: The primary mechanism for small molecule clearance (urea, creatinine, potassium). Because the treatment lasts longer, the concentration gradient remains stable, preventing the "disequilibrium syndrome" often seen in rapid IHD.
- Convection: Achieved through ultrafiltration. By spreading the fluid removal over 8+ hours, SLED allows for better plasma refill from the interstitial space, preventing the profound hypotension common in rapid fluid removal.
- Hemodynamic Stability: The slower rate of fluid removal and solute clearance allows the patient’s vascular system time to compensate, making it the preferred choice for patients on vasopressor support.
3. Extensive Clinical Indications & Usage
SLED is indicated for patients who require renal replacement therapy but cannot tolerate the rapid fluid and electrolyte shifts of conventional IHD.
Primary Indications
- Hemodynamically Unstable AKI: Patients requiring vasopressors or inotropic support.
- Severe Electrolyte Imbalance: Where gradual correction is safer (e.g., severe hyperkalemia or hypernatremia).
- Fluid Overload: Patients with pulmonary edema or refractory heart failure who require steady ultrafiltration.
- Severe Metabolic Acidosis: Particularly in cases of intoxication or sepsis-related metabolic derangement.
- Resource Management: Institutions where CRRT machines are unavailable or where nursing staff are more proficient with standard dialysis machines.
Patient Pre-Op Preparation
- Vascular Access: Placement of a large-bore, dual-lumen hemodialysis catheter (typically internal jugular or femoral).
- Anticoagulation Assessment: Evaluation of bleeding risk. If the patient is at high risk, heparin-free SLED or regional citrate anticoagulation (if the machine supports it) is utilized.
- Hemodynamic Baseline: Recording of MAP (Mean Arterial Pressure), vasopressor titration requirements, and CVP (Central Venous Pressure).
- Metabolic Profiling: Baseline serum electrolytes, BUN, creatinine, and arterial blood gas (ABG) to determine the prescription intensity.
4. Procedure Protocols and Post-Op Recovery
Execution Steps
- Machine Setup: Standard hemodialysis machine is primed with saline.
- Settings Prescription: The nephrologist prescribes the blood flow (Qb), dialysate flow (Qd), and ultrafiltration rate (UFR).
- Monitoring: Vital signs are recorded every 30–60 minutes.
- Safety Checks: Pressure limits (venous, arterial, and transmembrane) are adjusted to account for the longer duration.
Post-Op Recovery Protocol
- Vascular Access Care: Strict adherence to sterile dressing changes (chlorhexidine) to prevent Catheter-Related Bloodstream Infections (CRBSI).
- Metabolic Monitoring: Labs are typically drawn 2–4 hours post-treatment to assess the "rebound" effect of solutes.
- Hemodynamic Reassessment: Evaluation of vasopressor requirements; often, vasopressor doses can be weaned as fluid overload is corrected.
- Nutritional Support: Adjusting parenteral or enteral nutrition based on the protein loss associated with the dialysis session.
5. Risks, Side Effects, and Contraindications
Potential Complications
- Hypotension: Although less common than in IHD, rapid ultrafiltration can still lead to BP drops.
- Catheter Dysfunction: Longer sessions increase the risk of air emboli or clotting if not monitored correctly.
- Electrolyte Overshoot: Hypokalemia or hypophosphatemia can occur if the dialysate composition is not adjusted for the longer duration.
- Bleeding: If systemic anticoagulation (heparin) is used, the risk of hemorrhage in post-surgical patients is significant.
Contraindications
- Severe Coagulopathy: Where systemic heparinization is contraindicated and regional anticoagulation is unavailable.
- Lack of Access: Inability to secure a large-bore dialysis catheter.
- Morbidly Unstable Patients: In cases of extreme shock where even the slowest blood flow causes profound decompensation (where CRRT is strictly required).
6. Massive FAQ Section
1. How is SLED different from CRRT?
SLED uses standard dialysis machines and is delivered for a set window (6-12 hours), whereas CRRT is a continuous 24-hour process requiring specialized machines.
2. Can SLED be performed in a general ward?
Generally, no. SLED requires the same level of monitoring as IHD or CRRT and is strictly an ICU-based intervention due to the risk of hemodynamic collapse.
3. What is the biggest advantage of SLED?
The ability to provide high-quality solute clearance while maintaining hemodynamic stability in patients who are too sick for standard dialysis.
4. Does SLED require anticoagulation?
It depends on the patient's bleeding risk. Many patients on SLED receive heparin, but it can be performed heparin-free with frequent saline flushes.
5. Is SLED more expensive than CRRT?
Usually, SLED is significantly more cost-effective because it utilizes standard hospital dialysis machines and does not require the expensive, proprietary disposables associated with CRRT.
6. How often is SLED performed?
SLED can be performed daily or every other day, depending on the patient’s metabolic clearance requirements and renal recovery status.
7. What happens if the patient is hypotensive during SLED?
The ultrafiltration rate (UFR) is reduced or stopped, and the blood flow (Qb) may be decreased. Vasopressor support might be titrated upward by the bedside nurse.
8. Does SLED clear inflammatory cytokines?
Unlike high-volume CRRT, standard SLED is not specifically designed for cytokine removal, though there is some convective clearance of middle molecules.
9. Can SLED be used for drug overdose?
Yes, SLED is an effective modality for removing dialyzable toxins (e.g., lithium, methanol) due to its prolonged duration, which prevents the "rebound" of toxins from tissues into the blood.
10. What is the typical "dialysate" used in SLED?
Standard bicarbonate-buffered dialysate is used, similar to that found in chronic outpatient dialysis units, making the setup highly accessible.
7. Alternative Treatments
When SLED is not feasible or appropriate, clinicians may consider:
1. CRRT (Continuous Renal Replacement Therapy): The gold standard for the most unstable patients requiring 24/7 metabolic control.
2. IHD (Intermittent Hemodialysis): Appropriate for patients who have recovered enough hemodynamic stability to tolerate 3–4 hours of rapid treatment.
3. PD (Peritoneal Dialysis): Rarely used in the ICU setting, but sometimes utilized in pediatric populations or where vascular access is impossible.
4. SLED-f (SLED with filtration): A modified version utilizing hemofilters to provide convective clearance in addition to diffusive clearance for better middle-molecule removal.
Disclaimer: This guide is intended for educational purposes for medical professionals. Clinical decision-making should always be based on institutional protocols, patient-specific factors, and the direct oversight of a board-certified nephrologist or intensivist.
